TY - JOUR
T1 - Zeta (ξ), a growth-related opioid receptor in developing rat cerebellum
T2 - identification and characterization
AU - Zagon, Ian S.
AU - Gibo, Denise M.
AU - McLaughlin, Patricia J.
N1 - Funding Information:
Acknowledgement. This work was supported by NIH Grant NS-20500.
PY - 1991/6/14
Y1 - 1991/6/14
N2 - Endogenous opioids and opioid receptors (i.e. endogenous opioid systems) are expressed during neural ontogeny, and play a role in the development of the nervous system. Using [3H][Met5]-enkephalin, a potent ligand involved in neural growth, particularly cell proliferation, specific and saturable binding was detected in homogenates of 6-day-old rat cerebellum; the data were consistent with a single binding site. Scatchard analysis yielded a binding affinity (Kd) of 2.2 nM and a binding capacity (Bmax) of 22.3 fmol/mg protein. Binding was linear with protein concentration, dependent on time, temperature, and pH, and was sensitive to Na+, Mg2+, and guanyl nucleotides. Optimal binding required protease inhibitors, and pretreatment of the homogenates with trypsin markedly reduced binding, suggesting that the binding site was proteinaceous in character. The [Met5]-enkephalin binding site was an integral membrane protein located in the nuclear fraction. Competition experiments indicated that [Met5]-enkephalin was the most potent displacer of [3H][Met5]-enkephalin, and that binding was stereospecific. In the adult rat cerebellum, non-opioid receptor binding of [3H][Met5]-enkephalin was recorded. μ and κ receptors were also found in the developing rat cerebellum, while μ, δ, and κ receptors were recorded in adult cerebellar tissue. The function, pharmacological and biochemical characteristics, subcellular distribution, and temporal expression of the [Met5]-enkephalin binding site suggest the presence of a unique opioid receptor, termed zeta (ξ), in the developing nervous system.
AB - Endogenous opioids and opioid receptors (i.e. endogenous opioid systems) are expressed during neural ontogeny, and play a role in the development of the nervous system. Using [3H][Met5]-enkephalin, a potent ligand involved in neural growth, particularly cell proliferation, specific and saturable binding was detected in homogenates of 6-day-old rat cerebellum; the data were consistent with a single binding site. Scatchard analysis yielded a binding affinity (Kd) of 2.2 nM and a binding capacity (Bmax) of 22.3 fmol/mg protein. Binding was linear with protein concentration, dependent on time, temperature, and pH, and was sensitive to Na+, Mg2+, and guanyl nucleotides. Optimal binding required protease inhibitors, and pretreatment of the homogenates with trypsin markedly reduced binding, suggesting that the binding site was proteinaceous in character. The [Met5]-enkephalin binding site was an integral membrane protein located in the nuclear fraction. Competition experiments indicated that [Met5]-enkephalin was the most potent displacer of [3H][Met5]-enkephalin, and that binding was stereospecific. In the adult rat cerebellum, non-opioid receptor binding of [3H][Met5]-enkephalin was recorded. μ and κ receptors were also found in the developing rat cerebellum, while μ, δ, and κ receptors were recorded in adult cerebellar tissue. The function, pharmacological and biochemical characteristics, subcellular distribution, and temporal expression of the [Met5]-enkephalin binding site suggest the presence of a unique opioid receptor, termed zeta (ξ), in the developing nervous system.
UR - http://www.scopus.com/inward/record.url?scp=0025765370&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025765370&partnerID=8YFLogxK
U2 - 10.1016/0006-8993(91)90909-F
DO - 10.1016/0006-8993(91)90909-F
M3 - Article
C2 - 1655161
AN - SCOPUS:0025765370
SN - 0006-8993
VL - 551
SP - 28
EP - 35
JO - Brain research
JF - Brain research
IS - 1-2
ER -